葡萄糖激酶激活剂HMS5552治疗4周对中国2型糖尿病患者胰岛β细胞功能影响的研究（2015 CDS）-Poster and Presentation-Hua Medicine

Our Science

Science & Innovation

Pipeline

Dorzagliatin

mGluR5

Poster and Presentation

Peer Reviewed Publications

Announcements and Circulars

Listing Documents

Investor Presentation

IR Contact

Investor Calendar

Stock Information (2552.HK)

Corporate Communications

Portfolio Advisory Board

Senior Scientific Advisory Board

Our Science

> Our Science

> Poster and Presentation

Poster and Presentation

Peer Reviewed Publications

葡萄糖激酶激活剂HMS5552治疗4周对中国2型糖尿病患者胰岛β细胞功能影响的研究（2015 CDS）

2015 CDS

国产伦精品一区二区三区妓女

Jan 01, 2015

5249

Online link unavailable, presentation available upon request. (BD@huamedicine.com)

Return list

葡萄糖激酶激活剂HMS5552对2型糖尿病大鼠肝组织中葡萄糖激酶的调节作用（2015 CDS）

Validating the Dual-Modes of Action of HMS5552 A Novel Pancreatic- and Hepatic- Targeting Glucokinase Activator

About Us

Company Overview

Company History

Leadership Team

Portfolio Advisory Board

Senior Scientific Advisory Board

Partner

Media center

Research & Development

Inovation

Pipeline

Dorzagliatin

mGluR5

Company Publications

Peer Reviewed Publications

Investor Relations

Corporate Governance

Financial Report

Announcements & Circulars

Listing Documents

Investor Presentation

IR Contact

Investor Calendar

Stock information

Media

Company News

Media Releases

Video

Careers

Culture

Join Us

Product

贬耻补罢补苍驳狈颈苍驳(华堂宁?)

Focus Us

Privacy Statement Terms of Use

How we use cookies

Hua Medicine uses cookies to enable and improve the use of the website. By continuing to use the site, you consent to the use of these cookies. To learn more about cookies, please read our privacy statement.